3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
5
Gynecologic
1
Conditions
Carcinoma, Ovarian Epithelial
5
Ovarian Neoplasms
4
Endometrial Neoplasms
3
Testicular Neoplasms
2
Teratoma
2
Fallopian Tube Neoplasms
2
Central Nervous System Neoplasms
2
Breast Neoplasms
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Seminoma
1
Sarcoma
1
Recurrent Uterine Corpus Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Medulloblastoma
1
Liver Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Eosinophilic, Acute
1
Leukemia
1
Kidney Neoplasms
1
Familial ependymoma
1
Endometrial Adenocarcinoma
1
Endodermal Sinus Tumor
1
Interventions
Trastuzumab
4
liposomal doxorubicin
2
Interleukin-12 Subunit p35
2
Interleukin-12
2
Early Intervention, Educational
2
Docetaxel
2
veliparib
1
tipifarnib
1
temsirolimus
1
sargramostim
1
ixabepilone
1
entinostat
1
cediranib
1
Watchful Waiting
1
Vorinostat
1
Vinorelbine
1
Therapeutics
1
Taxes
1
TIC10 compound
1
Standard of Care
1
Sirolimus
1
Radiotherapy
1
Pyridoxine
1
Psychiatric Rehabilitation
1
Propranolol
1
Practice Guidelines as Topic
1
Physical Therapy Modalities
1
Pemetrexed
1
Paclitaxel
1
Mifepristone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
ixabepilone
×
Gynecologic
×
Clear all
NCT00005807
2018-10-09
BMS-247550
Albert Einstein College of Medicine
Phase 1
Completed
40 enrolled